Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in GPCR — Structure Therapeutics Inc.

CIK 70858 CHARLOTTE, NC
Back to GPCR Full portfolio

Position in GPCR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$30,238,857
+$19,291,096 QoQ
Shares Held
563,422
+148.1% QoQ
Ownership
0.790%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 190 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 95% Shared 0% None 5%

Common Shares in GPCR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. GPCR ranks #69 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,039,178 $1,509,650,884
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,291,053 $805,023,185
3 CYTK
Cytokinetics Inc
 4,635,709 $394,916,048
4 ARGX
Argenx SE
 400,234 $371,325,094
5 ALNY
Alnylam Pharmaceuticals, Inc.
 994,476 $299,367,107
6 JAZZ
Jazz Pharmaceuticals plc
 1,136,091 $273,763,844
7 TVTX
Travere Therapeutics, Inc.
 4,568,341 $259,527,450
8 RPRX
Royalty Pharma plc
 4,149,422 $232,658,090

All Filings in GPCR

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $30,238,857 563,422
2026-03-31 $10,947,761 227,132
2025-12-31 $2,203,203 31,678
2025-09-30 $385,812 13,779
2025-06-30 $288,449 13,908
2025-03-31 $959,629 55,438
2024-12-31 $1,469,495 54,185
2024-09-30 $534,798 12,185
2024-06-30 $3,312,855 84,361
2024-03-31 $131,836 3,076
2023-12-31 $3,118,300 76,504
2023-09-30 $497,846 9,874
2023-06-30 $70,002 1,684